ARTICLE | Company News
Cerus submits CE Mark
January 2, 2001 8:00 AM UTC
CERS and partner Baxter Healthcare (BAX) submitted a CE Mark application for approval to market the Intercept Platelet System in Europe. The system, which is in Phase III testing in the U.S., is used ...